Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring
The DOI matches its Crossref record; 10 of the 11 references it cites were found in a registry or an index.
Abstract
A combined contraceptive vaginal ring designed to last 12 months was tested at three clinic sites. This ring released approximately 1 mg of norethindrone acetate (NET-Ac) and 20 micrograms of ethinyl estradiol (EE) daily. A total of 60 women were enrolled to use the ring in a schedule of 3 weeks in/1 week out. Serum norethindrone (NET) and ethinyl estradiol (EE) levels were assayed twice weekly in cycles 6, 9, and 13. Mean NET concentrations between cycles 6 and 9 were relatively stable between 13 and 19 nmol/L but showed a 10%-21% decrease in all centers between cycles 9 and 13. Mean EE concentrations ranged from 75 to 103 pmol/L, but did not have the same decrease as NET between cycles 9 and 13. Cycles with progesterone peaks (> 9.6 nmol/L) compatible with some luteal activity occurred in 4% of cycles sampled in Sydney, 3% in Santo Domingo, and 26% in Los Angeles. Half of these cycles exhibited at least one progesterone value > 32 nmol/L with three of 18 occurring in noncompliant cycles. Heavier body weight was associated with increased probability of luteal activity. Based on serum estradiol peaks > 400 pmol/L, eight of 81 cycles appeared to have marked follicular activity with no luteal activity. No pregnancies occurred. Nausea was reported by about half the subjects in approximately 10% of the visits (mainly in the first 1-2 days in the first cycle immediately after ring insertion). Vomiting was reported by 20% of subjects early in the first cycle only. Headache was repo…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Use of a contraceptive patch (224) or vaginal ring (225) exerts a similar metabolic effect to that of oral contraceptives.”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [225]
Citations
Cites
Hormonal effects of the 300 μg norethisterone (NET) minipill
Landgren, B.-M., Balogh, Á. L., Shin, M., Lindberg, M., & Diczfalusy, E. R. (1979) · Contraception · doi:10.1016/s0010-7824(79)80038-4 · Cited by 95
Fraser, I. S., Lähteenmäki, P. L. A., Elomaa, K., Lacarra, M., Mishell, D. R., Alvarez, F., Brache, V., Weisberg, E., Hickey, M., Vallentine, P., et al. (1999) · Human Reproduction · doi:10.1093/humrep/14.8.1974 · Cited by 89
Self-citationBounds, W., Szarewski, A., Lowe, D., & Guillebaud, J. (1993) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(93)90252-8 · Cited by 51
Faúndes, A., Hardy, E. E., Reyes, Q., Pastene, L., & Portes-Carrasco, R. (1981) · Contraception · doi:10.1016/0010-7824(81)90006-8 · Cited by 37
The acceptability of a combined oestrogen/progestogen contraceptive vaginal ring
Weisberg, E., Fraser, I. S., Mishell, D. R., Lacarra, M., & Bardin, C. W. (1995) · Contraception · doi:10.1016/0010-7824(94)00005-h · Cited by 34
Self-citationVaginal epithelial surface appearances in women using vaginal rings for contraception
Fraser, I. S., Lacarra, M., Mishell, D. R., Alvarez, F., Brache, V., Lähteenmäki, P., Elomaa, K., Weisberg, E., & Nash, H. A. (2000) · Contraception · doi:10.1016/s0010-7824(00)00081-0 · Cited by 33
Self-citationA contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol
Ballagh, S. A., Mishell, D. R., Lacarra, M., Shoupe, D., Jackanicz, T. M., & Eggena, P. (1994) · Contraception · doi:10.1016/0010-7824(94)90011-6 · Cited by 30
Self-citationEffect of different insertion regimens on side effects with a combination contraceptive vaginal ring
Weisberg, E., Fraser, I. S., Lacarra, M., Mishell, D. R., & Jackanicz, T. M. (1997) · Contraception · doi:10.1016/s0010-7824(97)00133-9 · Cited by 24
Self-citationDose-finding study of a contraceptive ring releasing norethindrone acetate/ethinyl estradiol
Ballagh, S. A., Mishell, D. R., Jackanicz, T. M., Lacarra, M., & Eggena, P. (1994) · Contraception · doi:10.1016/0010-7824(94)90012-4 · Cited by 14
Self-citationVictor, A., Lithell, H., Selinus, I., & Vessby, B. O. (1985) · Contraception · doi:10.1016/0010-7824(85)90026-5 · Cited by 8
Cited by
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
Why consider vaginal drug administration?
Alexander, N. J., Baker, E., Kaptein, M., Karck, U., Miller, L., & Zampaglione, E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.01.025 · Cited by 269
Roumen, F. J. M. E., Apter, D., Mulders, T. M. T., & Dieben, T. O. M. (2001) · Human Reproduction · doi:10.1093/humrep/16.3.469 · Cited by 264
“Finland: D.Apter,vomiting, particularly in the first cycle of ring use (Ballagh et al., Helsinki; T.Haavanto, Tampere; A.M.Heikkinen, Kuopio; A.Kivelä,1994; Weisberg et al., 1999).”
BackgroundEfficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring
Dieben, T. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02124-5 · Cited by 249
“Although good efficacy was achieved, the ring did not maintain steroid release in the latter months of use.(7) More recently, a combined contraceptive vaginal ring that releases 15 g of ethinylestradiol and 120 g of the progestogen etonogestrel per day, at constant rates, has been developed.”
BackgroundResultHormonal contraceptives for contraception in overweight or obese women
Lopez, L. M., Bernholc, A., Chen, M., Grey, T. W., Otterness, C., Westhoff, C., Edelman, A., & Helmerhorst, F. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008452.pub4 · Cited by 182
Metadata
- Authors
- Weisberg, E., Fraser, I. S., Lacarra, M., Mishell, D. R., Alvarez, F., Brache, V, & Nash, H. A.
- Affiliations
- The University of Sydney (AU)
- University of Southern California (US)
- Profamilia (DO)
- Population Council (US)
- Corresponding author
- Weisberg, Edith
- Venue
- Contraception
- Publisher
- Elsevier BV
- Published
- 1999-05
- Volume
- 59
- Issue
- 5
- Pages
- 311-318
- ISSN
- 0010-7824 (ISSN-L)
- OpenAlex
- W2105085410
- Cited by
- 43
- References
- 11
- Citations by year
- 2026: 2 · 2024: 1 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 3 · 2012: 1
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Contraception (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Social Sciences › Political Science and International Relations › International Human Rights and Reproductive Law
- Keywords
- contraceptive vaginal ring, norethindrone acetate, ethinyl estradiol, luteal activity, follicular activity, serum progesterone, serum estradiol, bleeding patterns, nausea, headache, vaginal discharge, serum lipids, body weight, contraceptive efficacy, adverse effects, non-compliance, contraception
- MeSH terms
- Norethindrone Acetate, Adolescent, Adult, Contraceptive Agents, Female, Contraceptive Devices, Female, Corpus Luteum, Ethinyl Estradiol, Female, Ovarian Follicle, Humans, Menstrual Cycle, Norethindrone, Ovary, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring. https://app.cochat.ai/papers/10.1016/s0010-7824(99)00035-9
- The paper
- Weisberg, E., Fraser, I. S., Lacarra, M., Mishell, D. R., Alvarez, F., Brache, V, & Nash, H. A. (1999). Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring. Contraception. https://doi.org/10.1016/s0010-7824(99)00035-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.